Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1960 1
1964 2
1966 1
1967 1
1968 1
1969 1
1971 1
1973 2
1974 1
1975 1
1977 1
1979 3
1980 5
1981 5
1982 6
1983 10
1984 11
1985 19
1986 19
1987 17
1988 27
1989 24
1990 20
1991 15
1992 23
1993 37
1994 25
1995 46
1996 34
1997 47
1998 62
1999 63
2000 70
2001 57
2002 79
2003 104
2004 114
2005 145
2006 180
2007 210
2008 251
2009 309
2010 369
2011 418
2012 543
2013 653
2014 717
2015 774
2016 835
2017 977
2018 1084
2019 1363
2020 1534
2021 1872
2022 2228
2023 2206
2024 2545
2025 2956
2026 323

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20,918 results

Results by year

Filters applied: . Clear all
Page 1
JMJD2 regulates enhancer-promoter interactions via biomolecular condensate formation.
Jiang S, Liu X, Zhang Z, Yang M, Zhu X, Ma L, Zhao L, Ling X, Zhou Z, Wu Z, Qu J, Li H, Liang J, Deng Z, Tian Q, Huang X, Huang X, Tan J, Sun J, Wang J, Guallar D, Das PP, Pinello L, Wang L, Wu H, Huang DF, Wang J, Lin H, Bai J, Fan L, Chi W, Xiao X, Ding J. Jiang S, et al. Among authors: liang j. Nat Genet. 2025 Dec 16. doi: 10.1038/s41588-025-02415-8. Online ahead of print. Nat Genet. 2025. PMID: 41402457
Blood group antigens and malaria susceptibility.
Liu FF, Liang J, Gao M, Li K. Liu FF, et al. Among authors: liang j. Front Cell Infect Microbiol. 2025 Dec 10;15:1727335. doi: 10.3389/fcimb.2025.1727335. eCollection 2025. Front Cell Infect Microbiol. 2025. PMID: 41450567 Free PMC article. Review.
Prevalence and Outcomes of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease: A Multinational Study Across Asia.
Akiyama S, Park SH, Baek JE, Kanai S, Takahara N, Kasuga R, Nakamoto N, Takagi Y, Shinzaki S, Weng MT, Wei SC, Fujisawa T, Isayama H, Harindranath S, Desai D, Liang J, Park D, Park SJ, Mizuno S, Mochida S, Hei-Tung Lai K, Yan Mak JW, Khoo XH, Hilmi I, Ishikawa N, Gu YB, Zhang H, Oh SJ, Sano Y, Honzawa Y, Cheng TF, Matsuoka K, Kim DH, Fujima T, Matsuura M, Kim KO, Jang BI, Yen HH, Jung SA, Suen TL, Ni YH, Naganuma M. Akiyama S, et al. Among authors: liang j. Clin Gastroenterol Hepatol. 2025 Dec 1:S1542-3565(25)01004-3. doi: 10.1016/j.cgh.2025.11.020. Online ahead of print. Clin Gastroenterol Hepatol. 2025. PMID: 41330481 Free article.
A dysregulated hepcidin-iron axis impairs antiviral immunity and induces lethal liver pathology in neonates.
Xu Y, Chen X, Fang R, Wang X, Zhang Y, Ren H, Xiao Y, Ning Y, Li X, Chai C, Lei W, Zhong K, Liang J, Liang Q, Luo Y, He Q, Lin Z, Luo Z, Liu M, Liang W, Chen T, Gu X, Liu J, Lv J, Yao Z, Gong HB, Sun WY, He RR, Lew AM, Xia H, Wu Y, Zhou W, Wen Z, Chen Z, Zhang Y. Xu Y, et al. Among authors: liang j. Immunity. 2026 Jan 13;59(1):79-97.e11. doi: 10.1016/j.immuni.2025.11.001. Epub 2025 Dec 8. Immunity. 2026. PMID: 41365298 Free article.
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): final analysis of a randomised, open-label, international, phase 3 study.
Qin S, Gu S, Chan SL, Bai Y, Ren Z, Lin X, Chen Z, Jia W, Jin Y, Guo Y, Hu X, Meng Z, Liang J, Xiong J, Ren H, Yang F, Li W, Chen Y, Zeng Y, Xu L, Yuan X, Li D, Sultanbaev A, Pazgan-Simon M, Pisetska M, Melisi D, Ponomarenko D, Du J, Shi W, Cheng AL, Kaseb A, Vogel A; CARES-310 Study Group. Qin S, et al. Among authors: liang j. Lancet Oncol. 2025 Dec;26(12):1598-1611. doi: 10.1016/S1470-2045(25)00543-1. Lancet Oncol. 2025. PMID: 41308676 Clinical Trial.
Self-assembling peptides construct supramolecular materials.
Wang LY, Liang JX, Wang J, Han M, An HW, Wang H. Wang LY, et al. Among authors: liang jx. Chem Commun (Camb). 2026 Jan 13. doi: 10.1039/d5cc06446e. Online ahead of print. Chem Commun (Camb). 2026. PMID: 41527891 Review.
20,918 results
You have reached the last available page of results. Please see the User Guide for more information.